Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer

Joanna M. Brell, Khalid Matin, Terry Evans, Robert L. Volkin, Gauri J. Kiefer, James J. Schlesselman, Shelley Dranko, Linda Rath, Amy Schmotzer, Diana Lenzner, Ramesh K. Ramanathan

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of docetaxel and gefitinib as second-line therapy in gemcitabine pretreated patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences